What is ARTHROMAC

ARTHROMAC is a product for viscosupplementation, which is a safe, effective and well-established treatment in osteoarthritis (OA) consisting in injecting a hyaluronic acid-based solution into the affected synovial joint.
Hyaluronic acid (HA) is a major component of the synovial fluid and cartilage, and, thanks to its viscoelastic and rheological properties, is responsible for the lubrication and cushioning in joints.
It decreases friction between joint surfaces and protects soft tissue from trauma by acting as a shock absorbant. HA also have analgesic, anti-inflammatory, antioxidant and chondroprotective effects, stimulates proteoglycan, collagen and HA synthesis, and facilitates the evacuation of cartilaginous debris.

The concentration and molecular weight of HA in the synovial fluid are reduced in the patients who have osteoarthritis because its synthesis by the synovial and cartilage cells is disturbed. The protection of articular surfaces thus is strongly altered, the cartilage becomes vulnerable and exposed to structural degradations due to the forces of friction and compression.

Administered by a single injection, ARTHROMAC will restore the quantity and quality of HA in the synovial fluid and will ensure a good lubrication and shock absorption in the joint. At the symptomatic level, ARTHROMAC will provide a significant and long-term pain and stiffness relief.

ARTHROMAC relieves joint pain, improves articular mobility and protects cartilage.

ARTHROMAC is indicated for the treatment of all grades of osteoarthritis and is approved for all synovial joints. ARTHROMAC helps to avoid or delay the need for major surgery like joint replacement and can be used as a complement to minimally invasive procedures like arthroscopic lavage and debridement.